CD154‐expressing CMV‐specific T cells associate with freedom from DNAemia and may be protective in seronegative recipients after liver or intestine transplantation

…, M Reyes‐Mugica, BW Higgs, B Spishock… - Pediatric …, 2020 - Wiley Online Library
Cell‐mediated immunity to CMV, if known, could improve antiviral drug therapy in at‐risk
children and young adults with LT and IT. Host immunity has been measured with CMV‐specific …

Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients

…, G Bond, A Khanna, M Ningappa, B Spishock… - bioRxiv, 2021 - biorxiv.org
Assessment of T-cell immunity to the COVID-19 coronavirus requires reliable assays and is
of great interest, given the uncertain longevity of the antibody response. Some recent reports …

T-cell and antibody immunity after COVID-19 mRNA vaccines in healthy and immunocompromised subjects-An exploratory study

R Sindhi, C Ashokkumar, B Spishock, M Saunders… - medRxiv, 2021 - medrxiv.org
Background In recent studies, up to half of immunocompromised (IC) subject populations fail
to develop antibodies after COVID-19 vaccination. Purpose and Methods Here, we explore …

[PDF][PDF] Impaired Cellular and Antibody immunity after COVID-19 in chronically immunosuppressed transplant recipients

…, A Khanna, M Ningappa, B Spishock… - Journal of Surgery …, 2023 - fortuneonline.org
Assessment of cellular immunity to the SARS-CoV-2 coronavirus is of great interest in
chronically immunosuppressed transplant recipients (Tr), who are predisposed to infections and …

Cellular and Antibody Immunity after COVID-19 Vaccination at> 4-Month Follow Up in Immunocompetent and Immunocompromised Subjects

R Sindhi, C Ashokkumar, V Singh, B Spishock… - medRxiv, 2021 - medrxiv.org
We evaluated post-vaccination immunity after COVID-19 vaccination with serial changes in
cellular and antibody responses to the spike protein S, its S2 component which is conserved …

T-cell and antibody immunity after COVID-19 mRNA vaccines in healthy and immunocompromised subjects-An exploratory study.(preprint)

R Sindhi, C Ashokkumar, B Spishock, M Saunders… - 2021 - pesquisa.bvsalud.org
Background: In recent studies, up to half of immunocompromised (IC) subject populations
fail to develop antibodies after COVID-19 vaccination. Purpose and Methods: Here, we …

Parasites and human evolution

GH Perry - Evolutionary Anthropology: Issues, News, and …, 2014 - Wiley Online Library
Our understanding of human evolutionary and population history can be advanced by ecological
and evolutionary studies of our parasites. Many parasites flourish only in the presence …